Concord Biotech Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation

Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.